Antihypertensive Drug Target Genes and Epithelial Ovarian Cancer Risk: A Two-Sample Mendelian Randomization Study
International Journal of Women's Health · 2026-03 · Volume 18 · 1-10
DOI: 10.2147/ijwh.s579065 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Women's Health, 2026-03. Verfasst von Jing Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.
Zitieren
APA
Li, J., Feng, Y., & Shang, Y. (2026). Antihypertensive Drug Target Genes and Epithelial Ovarian Cancer Risk: A Two-Sample Mendelian Randomization Study. International Journal of Women's Health, Volume 18, 1-10. https://doi.org/10.2147/ijwh.s579065
Vancouver
Li J, Feng Y, Shang Y. Antihypertensive Drug Target Genes and Epithelial Ovarian Cancer Risk: A Two-Sample Mendelian Randomization Study. International Journal of Women's Health. 2026;Volume 18:1-10. doi:10.2147/ijwh.s579065
BibTeX
@article{Li2026,
author = {Li, Jing and Feng, Yali and Shang, Yuhong},
title = {Antihypertensive Drug Target Genes and Epithelial Ovarian Cancer Risk: A Two-Sample Mendelian Randomization Study},
journal = {International Journal of Women's Health},
year = {2026},
volume = {Volume 18},
pages = {1--10},
doi = {10.2147/ijwh.s579065}
}
EUVIMED